HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02696 HENLIUS

Market Closed 09-25 16:08:14

57.200

-0.450

-0.78%

High60.000	Low56.650	Vol159.30K
Open60.000	D1 Closing57.650	Amplitude5.81%
Mkt Cap31.17B	Tradable Cap19.91B	Total Shares545.00M
T/O9.08M	T/O Rate0.05%	Tradable Shares348.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02696","market":"HK","secType":"STK","nameCN":"HENLIUS","latestPrice":57.2,"timestamp":1790323694003,"preClose":57.65,"halted":0,"volume":159300,"delay":0,"changeRate":-0.007805724197744939,"floatShares":348000000,"shares":545000000,"eps":1.758258875187262,"marketStatus":"Market Closed","change":-0.45,"latestTime":"09-25 16:08:14","open":60,"high":60,"low":56.65,"amount":9076446,"amplitude":0.058109,"askPrice":57.2,"askSize":1600,"bidPrice":57.05,"bidSize":200,"shortable":3,"etf":0,"ttmEps":1.839623966728107,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":7,"adr":0,"listingDate":1569340800000,"exchange":"SEHK","adjPreClose":57.65,"openAndCloseTimeList":[[1790299800000,1790308800000],[1790312400000,1790323200000]],"volumeRatio":0.15418593024241042,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02696","defaultTab":"news","newsList":[{"id":"2669464543","title":"Amberstone Biosciences and Henlius Enter into Collaboration and License Agreement for Conditionally Activated T-Cell Engagers for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669464543?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:33","pubTimestamp":1790246003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","HK0000320264.USD","HK0000306701.USD","02696","HK0000320223.HKD","HK0000165453.HKD","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669358107","title":"Shanghai Fosun Unit Gets Global License for Two TCE Cancer Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2669358107","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669358107?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:17","pubTimestamp":1790158640,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical   unit Shanghai Henlius Biotech  signed a collaboration and exclusive license deal with Amberstone Biosciences for two T-cell engager products, according to a Wednesday Shanghai bourse filing.Under the deal, Henlius Biotech received exclusive global rights to research, develop, manufacture and commercialize the products for all human uses based on Amberstone's T-MATE technology platform and two designated targets.Henlius Biotech will pay Amberstone up to $236.2 million in upfront, research, development and regulatory milestone payments, plus up to $652 million in sales milestones, it said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1593","HK0000165453.HKD","02196","02696","600196","BK0012","BK1191","HK0000306685.HKD","BK0175","HK0000320223.HKD","BK1515","BK0028","BK0188","BK0239","XBI","HK0000306701.USD","BK4588","BK0060","BK0096","BK0196","BK0183","HK0000320264.USD","BK0187","BK4581","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197775203","title":"HENLIUS Enters Global Collaboration and Licensing Agreement with Amberstone for Two T-Cell Engager Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=1197775203","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197775203?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:03","pubTimestamp":1790154183,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) has announced that on September 23, 2026, the company entered into a collaboration and licensing agreement with Amberstone Biosciences, Inc. (\"Amberstone\", collectively with the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1161","HK0000320223.HKD","HK0000306685.HKD","02696","HK0000306701.USD","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669365101","title":"Shanghai Henlius Biotech, - to Pay Amberstone Upfront Payment of $4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2669365101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669365101?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:59","pubTimestamp":1790153966,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F09E:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","HK0000306701.USD","HK0000320264.USD","HK0000165453.HKD","HK0000306685.HKD","02696","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669101854","title":"Shanghai Henlius Biotech, - Enters Collaboration and License Agreement with Amberstone Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2669101854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669101854?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:59","pubTimestamp":1790153966,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F09E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000306685.HKD","HK0000306701.USD","HK0000320223.HKD","02696","BK1161","HK0000165453.HKD","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669018551","title":"Shanghai Henlius Biotech, - Agreement Covers Worldwide Research and Commercialization of Two T Cell Engager Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2669018551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669018551?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:59","pubTimestamp":1790153966,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F09E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000165453.HKD","HK0000320223.HKD","HK0000320264.USD","02696","HK0000306685.HKD","HK0000306701.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117397705","title":"HENLIUS Surges Over 8% on Pakistan Approval and Inclusion in National Essential Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=1117397705","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117397705?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:58","pubTimestamp":1789955899,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) saw its shares jump more than 8% in morning trading, with the stock last changing hands at HK$64.80, representing an 8.56% gain, and turnover reaching HK$20.10 million.On the news...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000306701.USD","HK0000320264.USD","HK0000165453.HKD","HK0000306685.HKD","VXUS","02696","BK4585","KCAI","BK4588","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668948860","title":"Shanghai FTZ Fund-Backed Henlius Enters Stock Connect List in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2668948860","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668948860?lang=en_us&edition=fundamental","pubTime":"2026-09-18 14:26","pubTimestamp":1789712768,"startTime":"0","endTime":"0","summary":"Shanghai FTZ fund-backed Henlius enters Stock Connect list in Hong KongShanghai Free Trade Zone Equity Investment Fund Management flagged multiple portfolio milestones across awards, policy designatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL1Ln00Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","HK0000320223.HKD","BK1230","HK0000320264.USD","HK0000165453.HKD","02696","BK1161","HK0000306685.HKD","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134723592","title":"Quarterly Rebalancing Alert: Huabao's HK Stock Connect Innovative Drug ETF (520880) Welcomes Five New Constituents While Dropping Three","url":"https://stock-news.laohu8.com/highlight/detail?id=1134723592","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134723592?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:20","pubTimestamp":1789471241,"startTime":"0","endTime":"0","summary":"The quarterly index rebalancing for HK Stock Connect innovative drug stocks is officially in effect as of September 14th, prompting a synchronized portfolio refresh for the Huabao Hang Seng HK Stock...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["520880","BK1161","HK0000306701.USD","HK0000320264.USD","HK0000165453.HKD","HK0000306685.HKD","02696","159316","FLHK","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170988037","title":"Henlius Secures NMPA Acceptance for 120 mg Denosumab Biosimilar HLX14 NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1170988037","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170988037?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:44","pubTimestamp":1789116273,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech, Inc. (Henlius) announced that China’s National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for the 120 mg (1.7 mL) per vial...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666880547","title":"Shanghai Henlius Says China Regulator Accepts NDA for 120 Mg Denosumab Biosimilar HLX14","url":"https://stock-news.laohu8.com/highlight/detail?id=2666880547","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666880547?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:31","pubTimestamp":1789115466,"startTime":"0","endTime":"0","summary":"Shanghai Henlius says China regulator accepts NDA for 120 mg denosumab biosimilar HLX14Shanghai Henlius Biotech received NMPA acceptance for an NDA covering a 120 mg (1.7 mL) vial of denosumab biosimi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL3LcRRc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320223.HKD","00656","BK1230","HK0000320264.USD","02696","HK0000165453.HKD","HK0000306685.HKD","HK0000306701.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666654201","title":"Shanghai Henlius Biotech, - Nda for 120 Mg Biosimilar Denosumab Hlx14 Accepted by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2666654201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666654201?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:30","pubTimestamp":1789115430,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN4530E0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000306685.HKD","HK0000306701.USD","HK0000320223.HKD","02696","BK1161","HK0000165453.HKD","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107437767","title":"Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=1107437767","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107437767?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:11","pubTimestamp":1788959461,"startTime":"0","endTime":"0","summary":"During the 2026 Yabuli Forum Summer Annual Meeting, Henlius (02696.HK) Executive Director and CEO Dr. Zhu Jun outlined the company's \"systematic globalization\" strategy in an in-depth conversation,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","HK0000306701.USD","LU2272731600.USD","LU2322448957.HKD","HK0000320223.HKD","LU2272731782.SGD","BK1574","BK1161","LU2322448791.USD","XPH","LNGR","HK0000165453.HKD","LU1992135399.USD","LU2272731865.HKD","159992","PPH","MEDX","BK4585","HK0000306685.HKD","LU1992135472.HKD","IBB","IE00B5TLWC47.USD","LU2473716301.USD","BK4588","IBBQ","06978","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394107","title":"Henlius Biotech Joins Two Chinese Stock Connect Programs; Shares Slide 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394107","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394107?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:28","pubTimestamp":1788762493,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech's  shares were included in Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect, effective Monday.The stock connect programs are a collaboration between the Hong Kong, Shanghai and Shenzhen stock exchanges, enabling international and mainland Chinese investors to trade securities in each other's markets.The biotech firm said its inclusion in the cross-border trading links would expand its shareholder base and boost the liquidity of its shares, Henlius said in a Monday disclosure.Shares of Henlius fell over 3% in Monday's afternoon trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["YANG","HK0000165453.HKD","02696","FLCH","ASHR","HK0000306685.HKD","02823","HK0000320223.HKD","YINN","KBA","XBI","KWEB","HK0000306701.USD","BK4588","CHAU","FXP","XPP","82843","02822","82823","ASHS","KCAI","02843","BK1161","BK4581","HK0000320264.USD","BK4585","82822","CWEB","YXI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176132061","title":"HENLIUS Joins Stock Connect Eligible Securities Roster","url":"https://stock-news.laohu8.com/highlight/detail?id=1176132061","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176132061?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:10","pubTimestamp":1788754215,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced its inclusion in the eligible securities list under both the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect schemes, following regulatory notices from the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLHK","HK0000320264.USD","HK0000306701.USD","161027","HK0000320223.HKD","HK0000306685.HKD","HK0000165453.HKD","BK1161","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117043556","title":"Henlius CEO Zhu Jun: AI Will Evolve from a Productivity Tool into a Transformative Catalyst for Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1117043556","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117043556?lang=en_us&edition=fundamental","pubTime":"2026-09-05 23:00","pubTimestamp":1788620428,"startTime":"0","endTime":"0","summary":"At the 2026 Yabuli Forum Summer Annual Meeting held in Chengdu from September 4-6, a key conversation unfolded regarding the future of pharmaceutical innovation. Dr. Zhu Jun, Executive Director and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","QTOC","HK0000306685.HKD","HK0000165453.HKD","HK0000320223.HKD","BK1161","HK0000306701.USD","02696","VTHR","CHAT","ARTY","AGIX","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158783895","title":"AI Integration Becomes Essential for Biopharma's Future, Says Henlius CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1158783895","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158783895?lang=en_us&edition=fundamental","pubTime":"2026-09-05 14:20","pubTimestamp":1788589217,"startTime":"0","endTime":"0","summary":"At the 2026 Yabuli Forum Summer Annual Meeting, held from September 4-6 in Chengdu, Sichuan, Zhu Jun, CEO of HENLIUS, stated that the primary mission of the healthcare industry is to help people live...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03069","AGIX","HK0000306701.USD","BK1574","CHAT","MRNY","HK0000306685.HKD","02696","BK1191","QTOC","AIPO","MRNX","VTHR","HK0000320223.HKD","BBP","HK0000320264.USD","ARTY","01477","HK0000165453.HKD","BK1161","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664813811","title":"Shanghai Henlius Biotech (SEHK:2696) Reports Strong Half Year Growth, Is It Overvalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664813811","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664813811?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:26","pubTimestamp":1788333964,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech (SEHK:2696) drew fresh attention after reporting half year 2026 sales of CNY 3,588.23 million and net income of CNY 430.44 million, alongside a new Hong Kong principal business address.\nShanghai Henlius Biotech’s recent half year update has come alongside a strong shift in market sentiment, with a 22.55% 1 month share price return and a 16.38% year to date share price return, even though the 1 year total shareholder return declined 11.43%.\nSpot fresh momentum in...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-biotech-sehk2696-reports-strong-half-year-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-biotech-sehk2696-reports-strong-half-year-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI","BK4585","HK0000165453.HKD","BK1161","HK0000306685.HKD","BK4581","02696","DCF","HK0000306701.USD","HK0000320264.USD","BK4588","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130168137","title":"HENLIUS Surges Nearly 7% in Morning Trade on Strong Overseas Revenue Growth and Citi's Upgraded Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=1130168137","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130168137?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:20","pubTimestamp":1787797214,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) climbed nearly 7% in early trading on the Hong Kong Stock Exchange, last up 5.86% at HK$72.3, with turnover reaching HK$14.17 million.The biopharmaceutical company released its...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648001328.SGD","LU1162221912.USD","HK0000320264.USD","LU1791807156.HKD","LU0320765646.SGD","LU1244550494.USD","LU1244550221.USD","02696","LU2236285917.USD","LU2125154778.USD","LU1201861249.SGD","FTXO","VXUS","LU2360032135.SGD","LU0052756011.USD","BK4207","BK4566","LU0203347892.USD","BK4585","HK0000306701.USD","LU1144417596.USD","BK4559","BK4588","LU0106831901.USD","HK0000165453.HKD","LU0310800965.SGD","LU0098860793.USD","LU0162691827.USD","LU1506573853.SGD","BK1161","LU0203345920.USD","LU2417539215.USD","LU0128525689.USD","LU0130517989.USD","KCAI","TFNS","C","BK4534","LU0477156953.USD","LU1244550577.SGD","LU0980610538.SGD","IE00BSNM7G36.USD","LU1366192091.USD","LU1668664300.SGD","LU0170899867.USD","LU2125154935.USD","LU2456880835.USD","HK0000306685.HKD","LU1074936037.SGD","LU0130102774.USD","HK0000320223.HKD","BK4504","LU2462157665.USD","IYF","LU0314106906.USD","LU1267930227.SGD","LU0072461881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102078176","title":"Global Industry Company Boosts Stake in HENLIUS with HK$15.94 Million Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1102078176","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102078176?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:40","pubTimestamp":1787748036,"startTime":"0","endTime":"0","summary":"Latest data from the Stock Exchange of Hong Kong reveals that on August 21, Global Industry Company increased its holdings in HENLIUS (02696) by 232,200 shares at an average price of HK$68.6666 per...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","EWH","HK0000320264.USD","HK0000306701.USD","GIC","HK0000320223.HKD","HK0000306685.HKD","HK0000165453.HKD","BK1161","02696"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0419},{"period":"1month","weight":-0.1625},{"period":"3month","weight":0.0306},{"period":"6month","weight":-0.2022},{"period":"1year","weight":-0.2286},{"period":"ytd","weight":0.0026}],"compareEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":-0.0446},{"period":"3month","weight":0.0811},{"period":"6month","weight":-0.0177},{"period":"1year","weight":-0.0746},{"period":"ytd","weight":-0.0437}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Shanghai Henlius Biotech Inc is a China-based company principally engaged in biopharmaceutical research and development, biopharmaceutical services and biopharmaceutical production and sales. The Company’s main products include HANQUYOU (trastuzumab for injection), HANNAIJIA (neratinib maleate), HANSIZHUANG (serplulimab injection), HANLIKANG (rituximab injection), HANDAYUAN (adalimumab injection), HANBEITAI (bevacizumab injection) and others. The Company’s products are mainly used in the treatment of adjuvant breast cancer, metastatic breast cancer, metastatic gastric cancer, metastatic non-squamous non-small cell lung cancer, polyarticular juvenile idiopathic arthritis and others. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.044394},{"month":2,"riseRate":0.714286,"avgChangeRate":0.117695},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.008815},{"month":4,"riseRate":0.857143,"avgChangeRate":0.12138},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.033714},{"month":6,"riseRate":0.571429,"avgChangeRate":0.085211},{"month":7,"riseRate":0.428571,"avgChangeRate":0.040127},{"month":8,"riseRate":0.571429,"avgChangeRate":0.005816},{"month":9,"riseRate":0,"avgChangeRate":-0.128277},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.025526},{"month":11,"riseRate":0.571429,"avgChangeRate":0.058675},{"month":12,"riseRate":0.714286,"avgChangeRate":-0.023816}],"exchange":"SEHK","name":"HENLIUS","nameEN":"HENLIUS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HENLIUS(02696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HENLIUS,02696,HENLIUS股票,HENLIUS股票老虎,HENLIUS股票老虎国际,HENLIUS行情,HENLIUS股票行情,HENLIUS股价,HENLIUS股市,HENLIUS股票价格,HENLIUS股票交易,HENLIUS股票购买,HENLIUS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HENLIUS(02696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}